Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein
BrainProtein
1 other identifier
interventional
64
1 country
1
Brief Summary
Multicenter, Prospective, randomized, comparative and controlled study about the beneficial effects in behavior and brain connectivity of different dietary patterns in 100 children with ADHD between 7 and 12 years, followed up for 3 months of nutritional therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Dec 2013
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2013
CompletedFirst Posted
Study publicly available on registry
May 17, 2013
CompletedStudy Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedResults Posted
Study results publicly available
September 10, 2014
CompletedMay 8, 2024
May 1, 2024
6 months
May 14, 2013
July 21, 2014
May 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Reaction Time at 3 Months
Reaction time during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.
3 months
Omission Errors at 3 Months
Omission errors during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach. (Test duration: 22 minutes)
3 months
Comission Errors at 3 Months
comission errors during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.(Test duration: 22 minutes)
3 months
Occipital Alpha Brainwaves Amplitudes at 3 Months
occipital alpha waves amplitudes during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.
3 months
Mu Waves-amplitude at 3 Months
Mu waves-amplitude during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.
3 months
Frontal Midline Theta Activity- Amplitude at 3 Months
Frontal midline theta activity- amplitude during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.
3 months
Secondary Outcomes (9)
Occipital Alpha Waves-frequency at 3 Months
3 months
Parietal Alpha Waves-frequency at 3 Months
3 months
Mu Wave Frequency at 3 Months
3 months
Frontal Midline Theta Activity- Frequency at 3 Months
3 months
Monastra Ratio at 3 Months
3 months
- +4 more secondary outcomes
Other Outcomes (3)
Weight at 3 Months
3 months
Body Mass Index at 3 Months
3 months
Number of Participants With Adverse Events as a Measure of Safety and Tolerability
Up to 8 months
Study Arms (2)
BP22042013
EXPERIMENTALThis group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low carbohydrate Diet
EXPERIMENTALthe second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements
Interventions
This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Eligibility Criteria
You may qualify if:
- ADHD diagnosed 12 months before
- no take medication
- BMI above the 25th percentile
- Wiesel score between 80 and 100 (about 120)
- Patients who agree to participate and whose guardians signed the informed consent form
You may not qualify if:
- eating disorders
- psychosis, bipolar disorder or depression
- kidney or liver failure
- diabetes
- diuretic or cortisone treatment
- haematological problems
- suprarenal diseases
- cancer
- Brain injury
- Cardiovascular or arrhythmia problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Spanish Foundation for Neurometrics Developmentlead
- PronoKal Foundationcollaborator
- Child Health Foundationcollaborator
Study Sites (1)
New Remedies
Liverpool, Merseyside, L1 0AH, United Kingdom
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Moises Aguilar Domingo
- Organization
- Spanish Foundation for Neurometrics Development
Study Officials
- PRINCIPAL INVESTIGATOR
Moises Aguilar-Domingo, PhD
Spanish Foundation for Neurometrics Development
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2013
First Posted
May 17, 2013
Study Start
December 1, 2013
Primary Completion
June 1, 2014
Study Completion
July 1, 2014
Last Updated
May 8, 2024
Results First Posted
September 10, 2014
Record last verified: 2024-05